BioLinker Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.63M

  • Investors
  • 6

BioLinker General Information

Description

Operator of a synthetic biology platform intended to accelerate recombinant protein production for research and industrial applications. The company offers cell-free expression kits, customizable gene synthesis, and a proprietary platform integrating genetic libraries and molecular display systems, enabling scientists to streamline the development of proteins for healthcare, agriculture, and biotechnology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Street 396
  • 2nd floor - San Jose Industrial Park, Cotia
  • San José, 06715-862
  • Brazil
+55 (11)
Primary Industry
Biotechnology
Other Industries
Other Commercial Services
Discovery Tools (Healthcare)
Corporate Office
  • Street 396
  • 2nd floor - San Jose Industrial Park, Cotia
  • San José, 06715-862
  • Brazil
+55 (11)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioLinker Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 06-Oct-2026 $1.63M Completed Generating Revenue
4. Angel (individual) 14-Jun-2022 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view BioLinker’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

BioLinker Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioLinker Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Axcell Aceleradora Accelerator/Incubator Minority
Fundação de Amparo à Pesquisa do Estado de São Paulo Limited Partner Minority
Angel (individual) Minority
Biominas Brasil Accelerator/Incubator
Cietec Accelerator/Incubator
You’re viewing 5 of 6 investors. Get the full list »

BioLinker FAQs

  • When was BioLinker founded?

    BioLinker was founded in 2018.

  • Where is BioLinker headquartered?

    BioLinker is headquartered in San José, Brazil.

  • What is the size of BioLinker?

    BioLinker has 12 total employees.

  • What industry is BioLinker in?

    BioLinker’s primary industry is Biotechnology.

  • Is BioLinker a private or public company?

    BioLinker is a Private company.

  • What is BioLinker’s current revenue?

    The current revenue for BioLinker is .

  • How much funding has BioLinker raised over time?

    BioLinker has raised $1.63M.

  • Who are BioLinker’s investors?

    Axcell Aceleradora, Fundação de Amparo à Pesquisa do Estado de São Paulo, , Biominas Brasil, and Cietec are 5 of 6 investors who have invested in BioLinker.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process